China National Pharmaceutical Group's (Sinopharm) chairman has said the firm has the capacity to provide more than one billion Covid-19 vaccine doses to the rest of the world in the second half of 2021.
That level of supply capability assumes vaccination demand in China is being met, Liu said at a panel of the Global Health Forum of the Boao Forum for Asia, according to a Reuters report.
